Del Carmen Jeffrey 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Del Carmen Jeffrey
Chief Commercial Officer
Transactions
- Tax Payment
Common stock, par value $0.001 per share
2024-12-09−2,355→ 18,053 total - Exercise/Conversion
Common stock, par value $0.001 per share
2024-12-09+8,039→ 20,408 total - Exercise/Conversion
Restricted Stock Units
2024-12-09−8,039→ 950,342 total→ Common Stock (8,039 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.